Source / episode info

• **Episode:**251
• **Title:**Divine Intervention Episode 251 – The HY Thyroid Podcast (For Step 1-3).
• **Published:**2020-07-29
• Source:Episode page

One-liner

This episode provides a comprehensive review of thyroid pathology and endocrinology, covering embryology (thyroglossal duct cyst vs branchial cleft cyst), the workup of nodules (TSH/RAI), hyperthyroidism management (Graves' disease treatment with I-131), various forms of hypothyroidism (Hashimoto's, myxedema coma), and differentiating thyroid cancers based on spread patterns (PTC via lymphatics vs FTC via blood).

High-yield summary

• Thyroglossal Duct Cyst (TGD): Midline neck mass derived from endoderm; moves with swallowing.
• Nodule Workup: Always check TSH first. Low TSH suggests a "hot" nodule requiring RAIU scan; normal/high TSH suggests a "cold" nodule requiring ultrasound and FNA.
• Graves' Disease Management: The definitive treatment for Graves' disease is Radioactive Iodine (I-131) ablation, not thyroidectomy.
• Thyroid Cancer Spread: Papillary Thyroid Cancer (PTC) spreads via the lymphatic system; Follicular Thyroid Cancer (FTC) spreads via the bloodstream (hematogenous).
• U-thyrate Syndrome: Seen in critical illness, starvation, or anorexia nervosa. Labs show low T3 and elevated Reverse T3 (rT3).
• Thyroid Storm Management: Initial treatment is a beta-blocker (e.g., Propranolol) to control symptoms and block peripheral conversion of T4 to T3; followed by anti-thyroid drugs (PTU/Methimazole) and iodine solution (SSKI).

Learning objectives

• Differentiate between thyroglossal duct cysts and branchial cleft cysts based on location and mobility.
• Interpret TSH levels and RAIU scan patterns to classify thyroid nodules (hot vs cold) and determine the cause of hyperthyroidism (Graves' vs thyroiditis).
• Outline the stepwise management for thyroid storm, prioritizing beta-blockers first.
• Recognize the characteristic lab findings (low T3, high rT3) associated with U-thyrate syndrome in critical illness or starvation.
• Differentiate the metastatic spread patterns of PTC (lymphatic) versus FTC (hematogenous).